Screener
Aclaris Therapeutics ACRS Gross Profit
Discontinued — last reported Q2 '26
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Aclaris Therapeutics’s reported figures.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
FAQ
- What is Aclaris Therapeutics's gross profit?
- Aclaris Therapeutics (ACRS) reported gross profit of $1.41M in Q2 2026.
- How has Aclaris Therapeutics's gross profit changed year-over-year?
- Aclaris Therapeutics's gross profit increased by 11.8% year-over-year, from $1.26M to $1.41M.
- What is the long-term trend for Aclaris Therapeutics's gross profit?
- Over 4 years (2021 to 2025), Aclaris Therapeutics's gross profit has grown at a 29.4% compound annual growth rate (CAGR), from $2.05M to $5.74M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Aclaris Therapeutics's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude